Global Passive Transdermal Drug Delivery Market Research Report 2018

March 2018 | 117 pages | ID: GCD0C6A0DD4QEN
QYResearch

Abstracts

In this report, the global Passive Transdermal Drug Delivery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Passive Transdermal Drug Delivery in these regions, from 2013 to 2025 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Passive Transdermal Drug Delivery market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• 3M
• Actavis, Inc.
• Bayer AG
• Boehringer Ingelheim GmbH
• Corium International, Inc.
• Echo Therapeutics, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson (Janssen Pharmaceuticals Inc.)
• Mylan N.V.
• Novartis AG
• Noven Pharmaceuticals, Inc.
• Transdermal Corp.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Microfluidics
• Smart Pill Technology (SPT)

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Passive Transdermal Drug Delivery Market Research Report 2018

1 PASSIVE TRANSDERMAL DRUG DELIVERY MARKET OVERVIEW

1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Passive Transdermal Drug Delivery Segment by Type (Product Category)
  1.2.1 Global Passive Transdermal Drug Delivery Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Passive Transdermal Drug Delivery Production Market Share by Type (Product Category) in 2017
  1.2.3 Microfluidics
  1.2.4 Smart Pill Technology (SPT)
1.3 Global Passive Transdermal Drug Delivery Segment by Application
  1.3.1 Passive Transdermal Drug Delivery Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market by Region (2013-2025)
  1.4.1 Global Passive Transdermal Drug Delivery Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Passive Transdermal Drug Delivery (2013-2025)
  1.5.1 Global Passive Transdermal Drug Delivery Revenue Status and Outlook (2013-2025)
  1.5.2 Global Passive Transdermal Drug Delivery Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Passive Transdermal Drug Delivery Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Passive Transdermal Drug Delivery Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Passive Transdermal Drug Delivery Production and Share by Manufacturers (2013-2018)
2.2 Global Passive Transdermal Drug Delivery Revenue and Share by Manufacturers (2013-2018)
2.3 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Passive Transdermal Drug Delivery Manufacturing Base Distribution, Sales Area and Product Type
2.5 Passive Transdermal Drug Delivery Market Competitive Situation and Trends
  2.5.1 Passive Transdermal Drug Delivery Market Concentration Rate
  2.5.2 Passive Transdermal Drug Delivery Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Passive Transdermal Drug Delivery Capacity and Market Share by Region (2013-2018)
3.2 Global Passive Transdermal Drug Delivery Production and Market Share by Region (2013-2018)
3.3 Global Passive Transdermal Drug Delivery Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Passive Transdermal Drug Delivery Consumption by Region (2013-2018)
4.2 North America Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
4.3 Europe Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
4.4 China Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
4.5 Japan Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)
4.7 India Passive Transdermal Drug Delivery Production, Consumption, Export, Import (2013-2018)

5 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Passive Transdermal Drug Delivery Production and Market Share by Type (2013-2018)
5.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2013-2018)
5.3 Global Passive Transdermal Drug Delivery Price by Type (2013-2018)
5.4 Global Passive Transdermal Drug Delivery Production Growth by Type (2013-2018)

6 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET ANALYSIS BY APPLICATION

6.1 Global Passive Transdermal Drug Delivery Consumption and Market Share by Application (2013-2018)
6.2 Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS

7.1 3M
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 3M Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Actavis, Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Bayer AG
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Bayer AG Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Boehringer Ingelheim GmbH
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Corium International, Inc.
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Echo Therapeutics, Inc.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 GlaxoSmithKline plc
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Mylan N.V.
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Novartis AG
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Passive Transdermal Drug Delivery Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Novartis AG Passive Transdermal Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Noven Pharmaceuticals, Inc.
7.12 Transdermal Corp.

8 PASSIVE TRANSDERMAL DRUG DELIVERY MANUFACTURING COST ANALYSIS

8.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Passive Transdermal Drug Delivery Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY MARKET FORECAST (2018-2025)

12.1 Global Passive Transdermal Drug Delivery Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Passive Transdermal Drug Delivery Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Passive Transdermal Drug Delivery Price and Trend Forecast (2018-2025)
12.2 Global Passive Transdermal Drug Delivery Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Passive Transdermal Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Passive Transdermal Drug Delivery Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Passive Transdermal Drug Delivery Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Passive Transdermal Drug Delivery
Figure Global Passive Transdermal Drug Delivery Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Passive Transdermal Drug Delivery Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Microfluidics
Table Major Manufacturers of Microfluidics
Figure Product Picture of Smart Pill Technology (SPT)
Table Major Manufacturers of Smart Pill Technology (SPT)
Figure Global Passive Transdermal Drug Delivery Consumption (K Units) by Applications (2013-2025)
Figure Global Passive Transdermal Drug Delivery Consumption Market Share by Applications in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Passive Transdermal Drug Delivery Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Passive Transdermal Drug Delivery Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Passive Transdermal Drug Delivery Major Players Product Capacity (K Units) (2013-2018)
Table Global Passive Transdermal Drug Delivery Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Passive Transdermal Drug Delivery Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Passive Transdermal Drug Delivery Capacity (K Units) of Key Manufacturers in 2017
Figure Global Passive Transdermal Drug Delivery Capacity (K Units) of Key Manufacturers in 2018
Figure Global Passive Transdermal Drug Delivery Major Players Product Production (K Units) (2013-2018)
Table Global Passive Transdermal Drug Delivery Production (K Units) of Key Manufacturers (2013-2018)
Table Global Passive Transdermal Drug Delivery Production Share by Manufacturers (2013-2018)
Figure 2017 Passive Transdermal Drug Delivery Production Share by Manufacturers
Figure 2017 Passive Transdermal Drug Delivery Production Share by Manufacturers
Figure Global Passive Transdermal Drug Delivery Major Players Product Revenue (Million USD) (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers
Table 2018 Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers
Table Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Passive Transdermal Drug Delivery Manufacturing Base Distribution and Sales Area
Table Manufacturers Passive Transdermal Drug Delivery Product Category
Figure Passive Transdermal Drug Delivery Market Share of Top 3 Manufacturers
Figure Passive Transdermal Drug Delivery Market Share of Top 5 Manufacturers
Table Global Passive Transdermal Drug Delivery Capacity (K Units) by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Capacity Market Share by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Capacity Market Share by Region (2013-2018)
Figure 2017 Global Passive Transdermal Drug Delivery Capacity Market Share by Region
Table Global Passive Transdermal Drug Delivery Production by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Production (K Units) by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Production Market Share by Region (2013-2018)
Figure 2017 Global Passive Transdermal Drug Delivery Production Market Share by Region
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) by Region (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2013-2018)
Table 2017 Global Passive Transdermal Drug Delivery Revenue Market Share by Region
Figure Global Passive Transdermal Drug Delivery Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Southeast Asia Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table India Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Passive Transdermal Drug Delivery Consumption (K Units) Market by Region (2013-2018)
Table Global Passive Transdermal Drug Delivery Consumption Market Share by Region (2013-2018)
Figure Global Passive Transdermal Drug Delivery Consumption Market Share by Region (2013-2018)
Figure 2017 Global Passive Transdermal Drug Delivery Consumption (K Units) Market Share by Region
Table North America Passive Transdermal Drug Delivery Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Passive Transdermal Drug Delivery Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Passive Transdermal Drug Delivery Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Passive Transdermal Drug Delivery Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Passive Transdermal Drug Delivery Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Passive Transdermal Drug Delivery Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Passive Transdermal Drug Delivery Production (K Units) by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Production Share by Type (2013-2018)
Figure Production Market Share of Passive Transdermal Drug Delivery by Type (2013-2018)
Figure 2017 Production Market Share of Passive Transdermal Drug Delivery by Type
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Passive Transdermal Drug Delivery by Type (2013-2018)
Figure 2017 Revenue Market Share of Passive Transdermal Drug Delivery by Type
Table Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2013-2018)
Figure Global Passive Transdermal Drug Delivery Production Growth by Type (2013-2018)
Table Global Passive Transdermal Drug Delivery Consumption (K Units) by Application (2013-2018)
Table Global Passive Transdermal Drug Delivery Consumption Market Share by Application (2013-2018)
Figure Global Passive Transdermal Drug Delivery Consumption Market Share by Applications (2013-2018)
Figure Global Passive Transdermal Drug Delivery Consumption Market Share by Application in 2017
Table Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2013-2018)
Figure Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2013-2018)
Table 3M Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3M Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure 3M Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Actavis, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis, Inc. Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Actavis, Inc. Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Bayer AG Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Corium International, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Corium International, Inc. Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Corium International, Inc. Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Echo Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure GlaxoSmithKline plc Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Mylan N.V. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan N.V. Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Mylan N.V. Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Passive Transdermal Drug Delivery Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Production Growth Rate (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Production Market Share (2013-2018)
Figure Novartis AG Passive Transdermal Drug Delivery Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure Passive Transdermal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Passive Transdermal Drug Delivery Major Manufacturers in 2017
Table Major Buyers of Passive Transdermal Drug Delivery
Table Distributors/Traders List
Figure Global Passive Transdermal Drug Delivery Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Passive Transdermal Drug Delivery Price (Million USD) and Trend Forecast (2018-2025)
Table Global Passive Transdermal Drug Delivery Production (K Units) Forecast by Region (2018-2025)
Figure Global Passive Transdermal Drug Delivery Production Market Share Forecast by Region (2018-2025)
Table Global Passive Transdermal Drug Delivery Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Passive Transdermal Drug Delivery Consumption Market Share Forecast by Region (2018-2025)
Figure North America Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Passive Transdermal Drug Delivery Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Passive Transdermal Drug Delivery Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Passive Transdermal Drug Delivery Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Passive Transdermal Drug Delivery Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Passive Transdermal Drug Delivery Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Passive Transdermal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Passive Transdermal Drug Delivery Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Passive Transdermal Drug Delivery Production (K Units) Forecast by Type (2018-2025)
Figure Global Passive Transdermal Drug Delivery Production (K Units) Forecast by Type (2018-2025)
Table Global Passive Transdermal Drug Delivery Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2018-2025)
Table Global Passive Transdermal Drug Delivery Price Forecast by Type (2018-2025)
Table Global Passive Transdermal Drug Delivery Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Passive Transdermal Drug Delivery Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source